Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is Z and Author is Zhang, Chun  [Clear All Filters]
2023
Zhang C, Xiao J, Fa L, Jiang F, Jiang H, Zhou L, Xu Z. Advances in the applications of mesenchymal stem cell-conditioned medium in ocular diseases. Exp Eye Res. 2023:109560.
Tan H-J, Deng Z-H, Zhang C, Deng H-W, Xiao H-M. CXADR promote epithelial-mesenchymal transition in endometriosis by modulating AKT/GSK-3β signaling. Cell Cycle. 2023:1-13.
2021
Suo L, Dai W, Chen X, Qin X, Li G, Song S, Zhang D, Zhang C. Proteomics analysis of N-methyl-d-aspartate-induced cell death in retinal and optic nerves. J Proteomics. 2021:104427.
2020
Lv X, Zhang C, Shuaizhen Q, Yu R, Zheng Y. Design of integrin αβ targeting self-assembled protein nanoparticles with RGD peptide. Biomed Pharmacother. 2020;128:110236.
2019
Huang J, Sun C, Su H, Zhang C, Xiong J. Bortezomib-Based Chemotherapy with Autologous Stem Cell Transplantation for Monoclonal Gammopathy of Renal Significance: A Case Report and Literature Review. Kidney Blood Press Res. 2019:1-12.
Xiong J, Wu M, Zhang Q, Zhang C, Xiong G, Ma L, Lu Z, Wang S. Proteomic analysis of mouse ovaries during the prepubertal stages. Exp Cell Res. 2019.
2018
Zhang R, Lu X, Wang H, You Y, Zhong Z, Zang S, Zhang C, Shi W, Li J, Wu Q, et al. IDA-intensified hematopoietic cell transplantation improves relapse and survival of high-risk acute leukemia patients with minimal residual disease. Biol Blood Marrow Transplant. 2018.
2015
Yen W-C, Fischer MM, Axelrod F, Bond C, Cain J, Cancilla B, Henner WR, Meisner R, Sato A, Shah J, et al. Targeting notch signaling with a notch2/notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency. Clin Cancer Res. 2015;21(9):2084-95.